Catalyst Wire Dossier Catalyst Wire Dossier

Individualized cancer vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Individualized cancer vaccine, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer [Phase 2]

See pricing